Criteria for use of amrinone lactate in hospitalized adult patients. 1990

P Burns, and J S Ondrejicka
Department of Pharmacy, University of Florida Health Science Center, Jacksonville.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002985 Clinical Protocols Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy. Protocols, Clinical,Research Protocols, Clinical,Treatment Protocols,Clinical Protocol,Clinical Research Protocol,Clinical Research Protocols,Protocol, Clinical,Protocol, Clinical Research,Protocols, Clinical Research,Protocols, Treatment,Research Protocol, Clinical,Treatment Protocol
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000676 Amrinone A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell. 5-Amino-(3,4'-bipyridine)-6(1H)-one,Amrinon,Cordemcura,Inocor,Win-40680,Wincoram,Win 40680,Win40680

Related Publications

P Burns, and J S Ondrejicka
January 1985, Critical care nurse,
P Burns, and J S Ondrejicka
May 1991, Clinical pharmacy,
P Burns, and J S Ondrejicka
October 1990, Clinical pharmacy,
P Burns, and J S Ondrejicka
August 1990, Clinical pharmacy,
P Burns, and J S Ondrejicka
October 1992, Clinical pharmacy,
P Burns, and J S Ondrejicka
March 1993, Clinical pharmacy,
P Burns, and J S Ondrejicka
April 1993, Journal of cardiothoracic and vascular anesthesia,
P Burns, and J S Ondrejicka
December 1993, Clinical pharmacy,
P Burns, and J S Ondrejicka
October 1987, Clinical chemistry,
Copied contents to your clipboard!